After Hours Gainer
KALV Kalvista Pharmaceuticals15.82-0.52-3.2%
After Hours:18.25+2.43 (+15.4%)
KalVista Pharmaceuticals Provides Update on Strong EKTERLY Launch with Preliminary Fourth Quarter and Full Year 2025 Revenue Results
Business WireThu, 8-Jan 4:05 PM
KALV Kalvista Pharmaceuticals15.29-0.17 (-1.1%)
KALV Kalvista Pharmaceuticals13.75+0.47 (+3.5%)